Isatuximab Plus Pomalidomide and Dexamethasone Association for Patients With AL Amyloidosis Not in VGPR or Better After Any Previous Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Discrete Choice Experiment
- Status
- COMPLETED
- Phase
- N/A
Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T Therapy
- Status
- COMPLETED
- Phase
- NA
A Study to Evaluate the Safety, Tolerability, Kinetics, Biodistribution and Repeatability of 11C-BMS-986196 After Intravenous (IV) Administration in Healthy Participants and After Repeat IV Administration in Participants With Multiple Sclerosis
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate the Bioavailability of Fedratinib When Administered in Different Ways to Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
Marizomib Central Nervous System (CNS)
- Status
- WITHDRAWN
- Phase
- PHASE2
A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2
A Study Evaluating Quality of Life for Participants With Atrial Fibrillation (AF) Following a Bleed (EQUAL-AF)
- Status
- COMPLETED
- Phase
- N/A
Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Nivolumab in Participants With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer (NSCLC) With Squamous and Non-Squamous Histology After Prior Chemotherapy Treated in Real World Settings in Greece and Cyprus
- Status
- COMPLETED
- Phase
- N/A
A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan
- Status
- COMPLETED
- Phase
- N/A
Carfilzomib and Belatacept for Desensitization
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma
- Status
- TERMINATED
- Phase
- PHASE3
Taste Assessment of Ozanimod
- Status
- COMPLETED
- Phase
- PHASE1
A "Physician & Patient-powered" Cohort Registry (MY MYELOMA)
- Status
- RECRUITING
- Phase
- N/A
Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2